Anna Nicolaou

Oxylipins are potent lipid mediators with increasing interest in clinical research. They are usually measured in systemic circulation and can provide a wealth of information regarding key biological processes such as inflammation, vascular tone, or blood coagulation. Although procedures still require harmonization to generate comparable oxylipin datasets, performing comprehensive profiling of circulating oxylipins in large studies is feasible and no longer restricted by technical barriers. However, it is essential to improve and facilitate the biological interpretation of complex oxylipin profiles to truly leverage their potential in clinical research. This requires regular updating of our knowledge about the metabolism and the mode of action of oxylipins, and consideration of all factors that may influence circulating oxylipin profiles independently of the studied disease or condition. This review aims to provide the readers with updated and necessary information regarding oxylipin metabolism, their different forms in systemic circulation, the current limitations in deducing oxylipin cellular effects from in vitro bioactivity studies, the biological and technical confounding factors needed to consider for a proper interpretation of oxylipin profiles.

With shrinking audiences, the industry now has to face its latest potential threat — AI

Chief Bob Iger says ‘slowdown' in experiences segment offset by box office success of films such as ‘Inside Out 2'

Financial Times: Impairment charges highlight collapse of lucrative business model.

The tycoon’s attempt to wrest control of his empire away from three of his children.

Media outlets play a critical role in US elections. As votes are cast, Americans depend on these news companies to “call” races in each state.

Why Billie Eilish and Olivia Rodrigo chose John Janick

US news groups fear president-elect will deliver on campaign threats through regulation, litigation and intimidation